Dubai PR Network, Online Press Release from Dubai and Middle East
 
Healthcare(Healthcare & Medicine)
Filter PR by
  
Ministry of Health and Prevention recalls some anti-hypertensive medications containing Valsartan
 

UAE, 10 July, 2018 - The Ministry of Health and Prevention (MOHAP) issued a circular ordering the recall of some antihypertensive medicines containing the active ingredient Valsartan, manufactured by Chinese company Zhejiang Huahai Pharmaceutical after the detection of impurities in the active ingredient.  This recall is a precautionary measure taken by the Ministry following the report issued by the European Medicines Agency indicating the detection of a contamination of the active ingredient with N-nitrosodimethylamine (NDMA), a chemical that might lead to cancer. Valsartan is a medicine used for the treatment of hypertension to prevent related cardiovascular complications.

According to the Ministry, the circular was released and addressed to all directors of the medical districts, directors of public and private hospitals, doctors, pharmacists and assistant pharmacists, directors of government and private pharmacies. The recall was issued after the Ministry's senior officials reviewed Ministerial Resolution No. (366) of 2010 governing the withdrawal, suspension, or prevention of distribution of pharmaceutical and medical products to protect public health.

Products affected by the MOHAP recall orders 

The circular includes a list of affected products, that have been registered with the Drug department of MOHAP. The recall order was sent to authorized agents and distributors of the recalled products with an order to quarantine all quantities of the products present within their warehouses. The circular has also directed that all healthcare practitioners and doctors should not prescribe or dispense the affected products and also advises patients to not discontinue use of the medicine unless they consult with the doctor to prescribe other alternatives registered with the Ministry.

The list of recalled products includes;  

Product Name                              Manufacturer Name

LABORATORIOS CINFA S.A- Spain              CINFAVAL

LABORATORIOS CINFA S.A - Spain             CO-CINFAVAL

PHARMA INTERNATIONAL CO. - Jordan           DIOSTAR PLUS

GLOBALPHARMA The Sanofi CO. LLC- UAE        VALDIO™

GLOBALPHARMA The Sanofi CO. LLC- UAE        VALDIO HCT

Novartis says hypertension medication Diovan is safe to use 

Meanwhile, MOHAP also explained that other medicines containing Valsartan, which are manufactured using the same active ingredient from other sources, are intact and unaffected--meaning that these are still safe to use. In connection with this, Swiss multinational pharmaceutical company Novartis informed the Ministry that their products containing Valsartan--Diovan, Co-Diovan Entresto and Exforge--are not impacted because these products do not contain the active ingredient from an external supplier, where the active ingredient was manufactured in a Novartis site in Ireland and Switzerland. Diovan is widely used to treat hypertension and all its related pharmaceutical products in the UAE and the rest of the world are safe to use.

Discontinuing the use of drugs as a result of misleading advertisements can cause serious complications on patients

The Ministry pointed out that the spreading of rumors without obtaining the proper information from official sources have serious consequences that can affect the community--causing doubt among patients that can drive them into stopping or modifying medication without obtaining proper advice from a healthcare professional. MOHAP is routinely doing quality checks through testing random samples to ensure quality of medicines in the country through the quality control of laboratory at the Dubai Science Park. This explanation was given in response to the recent spread of an inaccurate news report on social media covering the supposed withdrawal of Diovan, which caused panic among patients who stopped the use of medication, which badly affects their health.

MOHAP in constant contact with global pharmaceutical agencies to circulate any warning

The Ministry has affirmed that it is always in close coordination and communication with the FDA and the European and Australian Medicines agencies to get any updates and take any necessary actions as soon as possible to protect the health of patients and people in the country. 

Contacting MOHAP in case of rumors about medicines

The Ministry urged members of the community to contact them for any questions about medical products—including official information on medical matters, pharmaceutical products, medical warnings and details about approved medical devices. The Ministry can be contacted via 04-2301448; fax: 04-2301947; or e-mail: pv@moh.gov.ae  or through the link:

http://www.moh.gov.ae/ar/Services/Pages/TaminiService.aspx

 

 


Posted by : Dubai PR Network Editorial Team
Viewed 11389 times
PR Category : Healthcare & Medicine
Posted on : Tuesday, July 10, 2018  5:18:00 PM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : The Breastfeeding Friends Society provides education and psy...
Next Story : Nabadat initiative to provide free heart surgeries to more t...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Hackket's Bags of Style [12676-Views]
Tissot Introduces Chrono XL 3x3 Street Basketball Special Collection [12108-Views]
Introducing the Swim and Beachwear Summer Collection from Marks & Spencer [10693-Views]
Saint Honore [10230-Views]
Chloé Launches The New Cloud-shaped “rosie” Sunglasses [9998-Views]
BYS COSMETICS Now in UAE [9912-Views]
VBQ-presskit-denim-70s Capsule [8985-Views]
New Land Rover Defender Completes Tusk Testing to Support Lion Conservation in Kenya [8314-Views]
OMEGA Rocket Engine - Introducing the Master Chronometer Calibre 3861 [7619-Views]
Ministry of State for FNC Affairs Launches Forum Titled ‘Political Empowerment in the UAE' [6594-Views]
Electricity Most Searched Fuel Energy Term Online in UAE [6576-Views]
Natural and gentle haircare essentials for your little ones from Fifi & Friends' [6527-Views]
From the Big Screen to Real Life: Tag Heuer Unveils New Monaco Limited Edition At Exclusi... [6472-Views]
Eberhard & Co. Alfa Romeo Limited Edition [6466-Views]
Jaguar Land Rover & Bmw Group Announce Collaboration for Next Generation Electrification T... [6436-Views]
Rado Captain Cook Automatic Limited Edition with travel case' [6350-Views]
Britain's Greatest Test Driver, Norman Dewis Obe, Passes Away [6344-Views]
Aston Martin Produces First Cars at St Athan [6033-Views]
The Gucci Runway Makeup Looks for Cruise 2020 [5612-Views]
BMW Group and Jaguar Land Rover announce collaboration for next-generation electrification... [5563-Views]
Kickstart your summer workout with Ibn Battuta Mall's free indoor family Fun Run [5478-Views]
Certina DS PH200M collection' [5460-Views]
Vincitore Realty sells out 108 homes in the Dh375 million Benessere project in just three ... [5460-Views]
Backseat battles: kids driving their parents to distraction – and danger on the roads, Nis... [5411-Views]
Sony World Photography Awards Reveals New Categories for 2020 and Latest Sony Grant Recipi... [5258-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories